Pamidronate in the prevention of bone loss after liver transplantation: A randomized controlled trial

Transplant International

Volumn 22, Issue 2, 2009, Pages 198-206

  Monegal, Ana ^a   Guañabens, Núria ^a   Suárez, María Jesús ^b   Suárez, Francisco ^c   Clemente, Gerardo ^d   García González, Miguel ^e   De La Mata, Manuel ^f   Serrano, Trinidad ^g   Casafont, Fernando ^h   Torne, Santiago ⁱ   Barrios, Cesar ^j   Navasa, Miquel ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL JUAN CANALEJO   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ Instituto de Salud Carlos III   (Spain)

^j HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

more..

Author keywords

Bisphosphonates; Bone loss; Liver transplantation; Pamidronate

Indexed keywords

25 HYDROXYERGOCALCIFEROL; GLUCOSE; PAMIDRONIC ACID; PARATHYROID HORMONE; PLACEBO; VITAMIN D;

ADULT; AGED; ARTICLE; BACKACHE; BILIARY TRACT DISEASE; BONE ATROPHY; BONE DENSITY; BONE MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GLUCOSE INFUSION; GREATER TROCHANTER; HEADACHE; HORMONE DETERMINATION; HUMAN; HYPERTENSION; HYPOCALCEMIA; INFECTION; KIDNEY FAILURE; LIVER TRANSPLANTATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGICAL COMPLICATION; PARATHYROID HORMONE BLOOD LEVEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPINE RADIOGRAPHY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL;

ADULT; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; DIPHOSPHONATES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58149295447     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00763.x     Document Type: Article

References (27)

1. Ramsey-Goldman R, Dunn JE, Dunlop DD, et al. Icreased risk of fracture in patients receiving solid organ transplant. J Bone Miner Res 1999 14 : 456.
2. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med 1998 104 : 459.
3. Crosbie OM, Freaney R, McKenna MJ, Curry MP, Hegarty JE. Predicting bone loss following orthotopic liver transplantation. Gut 1999 44 : 430.
4. Katz IA, Epstein S. Posttransplantation bone disease. J Bone Miner Res 1992 7 : 123.
5. Haagsma EB, Thijn CJP, Post JG, Slooff MJTH, Gips CH. Bone disease after orthotopic liver transplantation. J Hepatol 1988 6 : 94.
6. McDonald JA, Dunstan CR, Dilworth P, et al. Bone loss after liver transplantation. Hepatology 1991 14 : 613.
7. Meys E, Fontanges E, Fourcade N, et al. Bone loss after orthotopic liver transpíantation. Am J Med 1994 97 : 445.
8. Porayko MIK, Wiesner RH, Hay YE, et al. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991 23 : 1462.
9. Navasa N, Monegal A, Guañabens N, et al. Bone fractures in liver transplant patients. Br J Rheumatol 1994 33 : 52.
10. Monegal A, Navasa M, Guañabens N, et al. Bone disease alter liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 2001 12 : 484.
11. Ninkovik M, Skingle SJ, Bearcroft PW, Bishop N, Alexander GJ, Compston JE. Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2000 12 : 931.
12. Eastell R, Dickson ER, Hodgson SF, et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991 14 : 296.
13. Monegal A, Navasa NI, Guañabens N, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997 60 : 148.
14. de Nijs RN, Jacobs JW, Lems WF, et al. Alendronate or alafacalcidiol in glucocorticoid-induced osteoporosis. N Engl J Med 2006 355 : 675.
15. Crawford B, Kam C, Pavlovic J, et al. Zolendronic acid prevents bone loss after liver transplantation. A randomized, double blind, placebo-controlled trial. Ann Intern Med 2006 144 : 239.
16. Bodingbauer M, Wekerle T, Pakrah B, et al. Prophylactic bisphosphonate treatment prevents bone fractures after liner transplantation. Am J Tranplant 2007 7 : 1763.
17. Atamaz F, Hepguler S, Akyildiz M, Karasu Z, Kilic M. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation. Osteoporos Int 2006 17 : 942.
18. Millonig G, Graziadei IW, Eicheler D, et al. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl 2005 11 : 960.
19. Reeves HL, Francis RM, Manas DM, Hudson M, Day CP. Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver trasplantation. Liver Transpl Surg 1998 4 : 404.
20. Dodidou P, Bruckner T, Hosch S, et al. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation Osteoporos Int 2003 14 : 82.
21. Pennisi P, Trombetti A, Giostra E, Mentha G, Rizzoli R, Fiore C. Pamidronate and osteoporosis prevention in liver transplant patients. Rheumatol Int 2007 27 : 251.
22. Ninkovic M, Love S, Tom BDM, Bearcroft PWP, Alenxander GJM, Compston JE. Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol 2002 37 : 93.
23. Pascual J, Torrealba J, Myres J, et al. Collapsing focal segmental glomerulosclerosis in liver transplant recipient on alendronate. Osteoporos Int 2007 18 : 1435.
24. Markowitz GS, Fine PL, D'Agati VD. Nephrotic syndrome after treatment with pamidronate. Am J Kidney Dis 2002 39 : 118.
25. Markowitz GS, Fine PL, Stack JI, et al. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 2003 64 : 281.
26. Kunin M, Kopolovic J, Avigdor A, Holtzman EJ. Collapsing glomerulopathy induced by long-term treatment with standad-doses pamidronate in myeloma patient. Nephrol Dial Transplant 2004 19 : 723.
27. Sauter M, Julg B, Porubsky S, et al. Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenic concept? Am J Kidney Dis 2006 47 : 1075.